A double-blind study of dezocine in cancer pain

A double-blind crossover comparison of intramuscularly administration of 10 mg dezocine (Wy 16225), 10 mg morphine, and placebo in ten patients with cancer pain has shown that a dezocine single dose is superior to placebo in producing relief of moderate to severe pain. No side effects were observed.